Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Puma tumbles as EBIT guidance disappoints

Published 25/01/2024, 12:58 am
Updated 25/01/2024, 12:58 am
© Reuters.

Sportswear brand Puma (PMMAF (OTC:PMMAF)) saw its shares fall Wednesday after the company announced its preliminary results for 2023 and its outlook for 2024.

The company said its performance was impacted by the "extraordinary Argentine peso devaluation." The company posted revenue growth of around 6.6%, with preliminary 2023 sales of approximately €8.6 billion.

However, the application of hyperinflationary accounting led to a sales decline in the fourth quarter, according to the company. Q4 sales declined by around 9.8% to approximately €1.98 billion.

Looking ahead, PUMA expects a mid-single-digit currency-adjusted sales growth and an EBIT in the range of €620 million to €700 million in 2024.

Reacting to the report, analysts at Citi, who have a Neutral rating and €60 price target on the stock, said the FY24 EBIT guidance was -18% below consensus due to the company's weaker sales outlook.

"FY24 EBIT guidance of €620-€700m is 18% below consensus at the midpoint (consensus: €726m, Citi: €727m), driven by just mid-single-digit cc FY24 growth (consensus: c.+11%, Citi: +9%)," they explained. "FY24 guidance is not related to the Peso devaluation. We expect a strong negative reaction to this print, given the scale of the FY24 downgrade."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.